MedCHAMPS News: Training on Health Economics and the Economics Evaluation of Health Programs
30/07/2010
The training on
Health Economics and Economic Evaluation of Health Program was prepared to
equip MedCHAMPS' researchers involved in WP6 with the necessary tools and
expertise to follow up with the economic evaluation of a pre-identified list of
policy interventions. Researchers from all of the MEDCHAMPS
participating countries were presented at this workshop. The objectives of
this training were: 1. To familiarize
participants with key principles of economic evaluation 2. To explore the use of
economic evaluation in previous IMPACT models 3. To identify the
appropriate approaches of economic evaluation specific to WP6 4. To acquire basic skills
for conducting MedCHAMPS economic analysis in the partner countries 5. To build professional
and support networks 6. To consolidate plans
for next steps in economic work The interventions
to be evaluated by the various country teams were also discussed and agreed
upon. The participants agreed on one cross-cutting intervention "Reducing
salt concentration in processed foods" to be evaluated in the context
of the four partners' countries. Each country was
also assigned an intervention to follow up and develop further. The selected
interventions are as follows: - OPTs: "Healthy
lifestyle promotion" - Syria: "CVD primary
prevention targeted to absolute risk levels" - Turkey: "Increase the
provision of CVD secondary prevention treatments for people with established
CHD or Stroke" - Tunisia: "Increase the
provision of acute care for acute MI" At the end of the training programme all agreed on considering using an
NHS trainee in the UK to support: i)
reviewing the cost-effectiveness literature on cardiovascular disease and
diabetes prevention, and ii) carrying out some cross-cutting economic
evaluation (salt reduction in processed foods), which would be led by Palestine.
An update on WP6 training will be added to the next annual meeting scheduled
for Tunis early next year (2011).
|
